Literature DB >> 17635577

Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction.

J K Nagpal1, B R Das.   

Abstract

BACKGROUND: Identification of changes in gene expression that occur in oral squamous cell carcinoma (OSCC), after sufficient characterization, may yield novel molecular markers that may be useful in the diagnosis and disease management of oral cancer.
MATERIALS AND METHODS: We used differential display-polymerase chain reaction (DD-PCR) to study critically the global gene expression profile of the oral tumour versus normal epithelium. The differential expression of fished out cDNA were confirmed by Northern blot and reverse transcription-PCR. The differentially expressed cDNA were cloned, sequenced and matched for homology in the GenBank database.
RESULTS: We identified 13 cDNA that showed differential expression. Out of these we selected four cDNA showing consistent reproducibility. One of the cDNA expressed exclusively in tumour had a homology to DEK, a putative oncogene, and is linked to leukaemia, various cancers, HIV infection and several autoimmune disorders. Another cDNA expressed only in tumour had homology to sorcin protein. Sorcin is a 22-kDa calcium-binding protein and is associated with drug resistance in various cell lines. Apparently, sorcin expression might be responsible for drug resistance of OSCC and poor prognosis. Another cDNA showing 10 times overexpression in cheek tumour as compared to normal had homology to CDK6 gene. Hence, it seems from our results that CDK6 is dysregulated during oral carcinogenesis. The fourth cDNA was overexpressed in normal as compared to cheek tumour, but did not show any match in BLAST search.
CONCLUSIONS: We conclude that there is an enormous significance of these differentially expressed cDNA in oral cancer progression as they can serve as cancer markers to be used for diagnosis and therapeutic intervention.

Entities:  

Mesh:

Year:  2007        PMID: 17635577     DOI: 10.1111/j.1365-2362.2007.01841.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  14 in total

Review 1.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

2.  The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Authors:  J Martinez-Useros; I Moreno; M J Fernandez-Aceñero; M Rodriguez-Remirez; A Borrero-Palacios; A Cebrian; T Gomez Del Pulgar; L Del Puerto-Nevado; W Li; A Puime-Otin; N Perez; M S Soengas; J Garcia-Foncillas
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

3.  Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer.

Authors:  Langmei Deng; Tao Su; Aimin Leng; Xiaomei Zhang; Meihua Xu; Lu Yan; Huan Gu; Guiying Zhang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

4.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

5.  TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.

Authors:  Sounak Gupta; Sarah H Johnson; George Vasmatzis; Binu Porath; Jeannette G Rustin; Priya Rao; Brian A Costello; Bradley C Leibovich; R Houston Thompson; John C Cheville; William R Sukov
Journal:  Mod Pathol       Date:  2017-03-24       Impact factor: 7.842

Review 6.  Mitosis, Focus on Calcium.

Authors:  Charlotte Nugues; Nordine Helassa; Lee P Haynes
Journal:  Front Physiol       Date:  2022-06-17       Impact factor: 4.755

7.  Gene expression profiling in sinonasal adenocarcinoma.

Authors:  Dominique Tripodi; Sylvia Quéméner; Karine Renaudin; Christophe Ferron; Olivier Malard; Isabelle Guisle-Marsollier; Véronique Sébille-Rivain; Christian Verger; Christian Géraut; Catherine Gratas-Rabbia-Ré
Journal:  BMC Med Genomics       Date:  2009-11-10       Impact factor: 3.063

8.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

9.  DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.

Authors:  Javier Martinez-Useros; Maria Rodriguez-Remirez; Aurea Borrero-Palacios; Irene Moreno; Arancha Cebrian; Teresa Gomez del Pulgar; Laura del Puerto-Nevado; Ricardo Vega-Bravo; Alberto Puime-Otin; Nuria Perez; Sandra Zazo; Clara Senin; Maria J Fernandez-Aceñero; Maria S Soengas; Federico Rojo; Jesus Garcia-Foncillas
Journal:  BMC Cancer       Date:  2014-12-16       Impact factor: 4.430

10.  Sorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosis.

Authors:  Vasiliki S Lalioti; Andrea Ilari; David J O'Connell; Elena Poser; Ignacio V Sandoval; Gianni Colotti
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.